[
  {
    "sentence": "Approval was obtained from the Lanka Hospitals medical and research committee.RESULTS\nA total of 169 neutropenic episodes were identified; 115 (68%) of such neutropenic episodes were related to chemotherapy, whereas 54 (32%) episodes were related to disease (Fig 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Fifteen percent of patients had only one episode of neutropenic sepsis during the study period, whereas 85% had more than one episode of neutropenic sepsis (Fig 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Acute leukemia/myelodysplastic syndrome, lymphoproliferative disorders, and plasma cell disorders accounted for 23%, 69%, and 8% of patients, respectively, in the group neutropenia related to chemotherapy (Fig 1C), whereas the majority of patients were male, 54% (Fig 1D).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The median age of patients who had CINS was 56 years, whereas that of those who had no sepsis was 53 years (P = .49; Fig 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The median time to neutropenia was 9 days for those in the sepsis group compared with 8 days in the group that had no sepsis (P = .64; Fig 2D).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel D",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Age and Time From CTN, NTS, CRP, N, P, H, TTA, A, G, IP, and DN in Chemotherapy-Induced and Disease-Induced neutropenia\n\n\n\nVariable\nChemotherapy-Induced Neutropenia\nDisease-Induced Neutropenia\n\n\nSepsis\nNo Sepsis\nSepsis\nNo Sepsis\n\n\n\n\nAge, years\n\n\n\n\n\n\n Mean (SD)\n50.40 (19.25)\n48.56 (19.83)\n64.33 (7.57)\n60.13 (7.84)\n\n\n Median (IQR)\n56.00 (36.00)\n53.00 (37.00)\n58.00 (15.00)\n58.00 (0.00)\n\n\n P\n\nCIN P = .49\nDIN P = .13\n\n\n\nSepsis P = .04\nNo sepsis P = .01\n\n\nCTN\n\n\n\n\n\n\n Mean (SD)\n9.34 (5.15)\n8.54 (3.73)\nNA\nNA\n\n\n Median (IQR)\n9.00 (5.00)\n8.00 (5.00)\nNA\nNA\n\n\n P\n\nCIN P = .64\nNA\nNA\n\n\nNTS\n\n\n\n\n\n Mean (SD)\n1.46 (1.120)\nNA\nNA\nNA\n\n\n Median (IQR)\n1.00 (0.00)\nNA\nNA\nNA\n\n\n P\n\nNA\nNA\nNA\nNA\n\n\nCRP\n\n\n\n\n\n\n Mean (SD)\n84.1 (98.5)\nNA\n80.0 (92.4)\nNA\n\n\n Median (IQR)\n47.6 (81.4)\nNA\n44.7 (133.1)\nNA\n\n\n P\n\nSepsis P = .83\n\n\nN\n\n\n\n Mean (SD)\n0.24 (0.32)\n0.62(0.29)\n0.45 (0.33)\n0.50 (0.36)\n\n\n Median (IQR)\n0.06 (0.46)\n0.69 (0.52)\n0.36 (0.66)\n0.50 (0.55)\n\n\n P\n\nCIN P = .000\nDIN P = .6176\n\n\n\nSepsis P = .018\nNo sepsis P = .02\n\n\nP\n\n\n\n Mean (SD)\n169.3 (134.9)\n186.6 (127.6)\n27.00 (26.66)\n48.0 (78.9)\n\n\n Median (IQR)\n139.0 (117.0)\n183.0 (132.0)\n16.00 (17.00)\n20.0 (24.0)\n\n\n P\n\nCIN P = .22\nDIN P = .47\n\n\n\nSepsis P = .00\nNo sepsis P = .00\n\n\nH\n\n\n\n Mean (SD)\n9.435 (1.81)\n10.100 (2.07)\n7.989 (0.85)\n8.61 (1.84)\n\n\n Median (IQR)\n9.000 (2.30)\n9.850 (2.85)\n8.000 (1.40)\n8.80 (1.75)\n\n\n P\n\nCIN P = .05\nDIN P = .08\n\n\n\nSepsis P = .01\nNo sepsis P = .00\n\n\nTTA\n\n\n\n Mean (SD)\n28.84 (14.91)\nNA\n37.78 (25.87)\nNA\n\n\n Median (IQR)\n20.00 (20.00)\nNA\n20.00 (40.00)\nNA\n\n\n P\n\nSepsis P = .48\n\n\nA\n\n\n\n\n\n\n Mean (SD)\n5.90 (4.30)\nNA\n5.22 (5.45)\nNA\n\n\n Median (IQR)\n4.00 (3.00)\nNA\n3.00 (5.50)\nNA\n\n\n P\n\nSepsis P = .0787\n\n\nG\n\n\n\n\n\n\n Mean (SD)\n4.00 (2.51)\nNA\n2.86 (3.18)\nNA\n\n\n Median (IQR)\n3.00 (4.00)\nNA\n1.00 (1.00)\nNA\n\n\n P\n\nSepsis P = .04\n\n\nIP\n\n\n\n\n\n\n Mean (SD)\n6.74 (5.36)\nNA\n6.78 (7.56)\nNA\n\n\n Median (IQR)\n5.00 (4.00)\nNA\n3.00 (8.50)\nNA\n\n\n P\n\nSepsis P = .2828\n\n\nDN\n\n\n\n\n\n\n Mean (SD)\n4.07 (3.04)\n4.37 (5.22)\nNA\nNA\n\n\n Median (IQR)\n3.00 (4.00)\n2.50 (3.75)\nNA\nNA\n\n\n P\n\nCIN P = .35\n\n\n\nOpen in a new tab\nAbbreviations: A, duration of antibiotics; CIN, chemotherapy-induced neutropenia; CRP, C-reactive protein; CSF, colony stimulating factors; CTN, chemotherapy to neutropenia in days; DIN, disease-induced neutropenia; DN, duration of neutropenia; G, duration of CSF; H, minimum hemoglobin; IP, inpatient stay; N, minimum neutrophil count; NA, not available; NTS, time from neutropenia to sepsis; P, minimum platelet count; SD, standard deviation; TTA, time to antibiotics from admission or from the onset of sepsis.The median neutrophil count in the group that had sepsis was 0.06, whereas it was 0.69 in the group that had no sepsis (P < .05; Fig 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "There was no difference in the CRP, median duration of antibiotic usage, CRP, GCSF usage, duration of neutropenia and hospital stay in the CINS group compared with the DINS group (Table 2; Fig 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Approval was obtained from the Lanka Hospitals medical and research committee.RESULTS\nA total of 169 neutropenic episodes were identified; 115 (68%) of such neutropenic episodes were related to chemotherapy, whereas 54 (32%) episodes were related to disease (Fig 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Fifteen percent of patients had only one episode of neutropenic sepsis during the study period, whereas 85% had more than one episode of neutropenic sepsis (Fig 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Acute leukemia/myelodysplastic syndrome, lymphoproliferative disorders, and plasma cell disorders accounted for 23%, 69%, and 8% of patients, respectively, in the group neutropenia related to chemotherapy (Fig 1C), whereas the majority of patients were male, 54% (Fig 1D).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The median age of patients who had CINS was 56 years, whereas that of those who had no sepsis was 53 years (P = .49; Fig 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The median time to neutropenia was 9 days for those in the sepsis group compared with 8 days in the group that had no sepsis (P = .64; Fig 2D).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel D",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Age and Time From CTN, NTS, CRP, N, P, H, TTA, A, G, IP, and DN in Chemotherapy-Induced and Disease-Induced neutropenia\n\n\n\nVariable\nChemotherapy-Induced Neutropenia\nDisease-Induced Neutropenia\n\n\nSepsis\nNo Sepsis\nSepsis\nNo Sepsis\n\n\n\n\nAge, years\n\n\n\n\n\n\n Mean (SD)\n50.40 (19.25)\n48.56 (19.83)\n64.33 (7.57)\n60.13 (7.84)\n\n\n Median (IQR)\n56.00 (36.00)\n53.00 (37.00)\n58.00 (15.00)\n58.00 (0.00)\n\n\n P\n\nCIN P = .49\nDIN P = .13\n\n\n\nSepsis P = .04\nNo sepsis P = .01\n\n\nCTN\n\n\n\n\n\n\n Mean (SD)\n9.34 (5.15)\n8.54 (3.73)\nNA\nNA\n\n\n Median (IQR)\n9.00 (5.00)\n8.00 (5.00)\nNA\nNA\n\n\n P\n\nCIN P = .64\nNA\nNA\n\n\nNTS\n\n\n\n\n\n Mean (SD)\n1.46 (1.120)\nNA\nNA\nNA\n\n\n Median (IQR)\n1.00 (0.00)\nNA\nNA\nNA\n\n\n P\n\nNA\nNA\nNA\nNA\n\n\nCRP\n\n\n\n\n\n\n Mean (SD)\n84.1 (98.5)\nNA\n80.0 (92.4)\nNA\n\n\n Median (IQR)\n47.6 (81.4)\nNA\n44.7 (133.1)\nNA\n\n\n P\n\nSepsis P = .83\n\n\nN\n\n\n\n Mean (SD)\n0.24 (0.32)\n0.62(0.29)\n0.45 (0.33)\n0.50 (0.36)\n\n\n Median (IQR)\n0.06 (0.46)\n0.69 (0.52)\n0.36 (0.66)\n0.50 (0.55)\n\n\n P\n\nCIN P = .000\nDIN P = .6176\n\n\n\nSepsis P = .018\nNo sepsis P = .02\n\n\nP\n\n\n\n Mean (SD)\n169.3 (134.9)\n186.6 (127.6)\n27.00 (26.66)\n48.0 (78.9)\n\n\n Median (IQR)\n139.0 (117.0)\n183.0 (132.0)\n16.00 (17.00)\n20.0 (24.0)\n\n\n P\n\nCIN P = .22\nDIN P = .47\n\n\n\nSepsis P = .00\nNo sepsis P = .00\n\n\nH\n\n\n\n Mean (SD)\n9.435 (1.81)\n10.100 (2.07)\n7.989 (0.85)\n8.61 (1.84)\n\n\n Median (IQR)\n9.000 (2.30)\n9.850 (2.85)\n8.000 (1.40)\n8.80 (1.75)\n\n\n P\n\nCIN P = .05\nDIN P = .08\n\n\n\nSepsis P = .01\nNo sepsis P = .00\n\n\nTTA\n\n\n\n Mean (SD)\n28.84 (14.91)\nNA\n37.78 (25.87)\nNA\n\n\n Median (IQR)\n20.00 (20.00)\nNA\n20.00 (40.00)\nNA\n\n\n P\n\nSepsis P = .48\n\n\nA\n\n\n\n\n\n\n Mean (SD)\n5.90 (4.30)\nNA\n5.22 (5.45)\nNA\n\n\n Median (IQR)\n4.00 (3.00)\nNA\n3.00 (5.50)\nNA\n\n\n P\n\nSepsis P = .0787\n\n\nG\n\n\n\n\n\n\n Mean (SD)\n4.00 (2.51)\nNA\n2.86 (3.18)\nNA\n\n\n Median (IQR)\n3.00 (4.00)\nNA\n1.00 (1.00)\nNA\n\n\n P\n\nSepsis P = .04\n\n\nIP\n\n\n\n\n\n\n Mean (SD)\n6.74 (5.36)\nNA\n6.78 (7.56)\nNA\n\n\n Median (IQR)\n5.00 (4.00)\nNA\n3.00 (8.50)\nNA\n\n\n P\n\nSepsis P = .2828\n\n\nDN\n\n\n\n\n\n\n Mean (SD)\n4.07 (3.04)\n4.37 (5.22)\nNA\nNA\n\n\n Median (IQR)\n3.00 (4.00)\n2.50 (3.75)\nNA\nNA\n\n\n P\n\nCIN P = .35\n\n\n\nOpen in a new tab\nAbbreviations: A, duration of antibiotics; CIN, chemotherapy-induced neutropenia; CRP, C-reactive protein; CSF, colony stimulating factors; CTN, chemotherapy to neutropenia in days; DIN, disease-induced neutropenia; DN, duration of neutropenia; G, duration of CSF; H, minimum hemoglobin; IP, inpatient stay; N, minimum neutrophil count; NA, not available; NTS, time from neutropenia to sepsis; P, minimum platelet count; SD, standard deviation; TTA, time to antibiotics from admission or from the onset of sepsis.The median neutrophil count in the group that had sepsis was 0.06, whereas it was 0.69 in the group that had no sepsis (P < .05; Fig 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "There was no difference in the CRP, median duration of antibiotic usage, CRP, GCSF usage, duration of neutropenia and hospital stay in the CINS group compared with the DINS group (Table 2; Fig 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Approval was obtained from the Lanka Hospitals medical and research committee.RESULTS\nA total of 169 neutropenic episodes were identified; 115 (68%) of such neutropenic episodes were related to chemotherapy, whereas 54 (32%) episodes were related to disease (Fig 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Fifteen percent of patients had only one episode of neutropenic sepsis during the study period, whereas 85% had more than one episode of neutropenic sepsis (Fig 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Acute leukemia/myelodysplastic syndrome, lymphoproliferative disorders, and plasma cell disorders accounted for 23%, 69%, and 8% of patients, respectively, in the group neutropenia related to chemotherapy (Fig 1C), whereas the majority of patients were male, 54% (Fig 1D).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The median age of patients who had CINS was 56 years, whereas that of those who had no sepsis was 53 years (P = .49; Fig 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The median time to neutropenia was 9 days for those in the sepsis group compared with 8 days in the group that had no sepsis (P = .64; Fig 2D).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel D",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Age and Time From CTN, NTS, CRP, N, P, H, TTA, A, G, IP, and DN in Chemotherapy-Induced and Disease-Induced neutropenia\n\n\n\nVariable\nChemotherapy-Induced Neutropenia\nDisease-Induced Neutropenia\n\n\nSepsis\nNo Sepsis\nSepsis\nNo Sepsis\n\n\n\n\nAge, years\n\n\n\n\n\n\n Mean (SD)\n50.40 (19.25)\n48.56 (19.83)\n64.33 (7.57)\n60.13 (7.84)\n\n\n Median (IQR)\n56.00 (36.00)\n53.00 (37.00)\n58.00 (15.00)\n58.00 (0.00)\n\n\n P\n\nCIN P = .49\nDIN P = .13\n\n\n\nSepsis P = .04\nNo sepsis P = .01\n\n\nCTN\n\n\n\n\n\n\n Mean (SD)\n9.34 (5.15)\n8.54 (3.73)\nNA\nNA\n\n\n Median (IQR)\n9.00 (5.00)\n8.00 (5.00)\nNA\nNA\n\n\n P\n\nCIN P = .64\nNA\nNA\n\n\nNTS\n\n\n\n\n\n Mean (SD)\n1.46 (1.120)\nNA\nNA\nNA\n\n\n Median (IQR)\n1.00 (0.00)\nNA\nNA\nNA\n\n\n P\n\nNA\nNA\nNA\nNA\n\n\nCRP\n\n\n\n\n\n\n Mean (SD)\n84.1 (98.5)\nNA\n80.0 (92.4)\nNA\n\n\n Median (IQR)\n47.6 (81.4)\nNA\n44.7 (133.1)\nNA\n\n\n P\n\nSepsis P = .83\n\n\nN\n\n\n\n Mean (SD)\n0.24 (0.32)\n0.62(0.29)\n0.45 (0.33)\n0.50 (0.36)\n\n\n Median (IQR)\n0.06 (0.46)\n0.69 (0.52)\n0.36 (0.66)\n0.50 (0.55)\n\n\n P\n\nCIN P = .000\nDIN P = .6176\n\n\n\nSepsis P = .018\nNo sepsis P = .02\n\n\nP\n\n\n\n Mean (SD)\n169.3 (134.9)\n186.6 (127.6)\n27.00 (26.66)\n48.0 (78.9)\n\n\n Median (IQR)\n139.0 (117.0)\n183.0 (132.0)\n16.00 (17.00)\n20.0 (24.0)\n\n\n P\n\nCIN P = .22\nDIN P = .47\n\n\n\nSepsis P = .00\nNo sepsis P = .00\n\n\nH\n\n\n\n Mean (SD)\n9.435 (1.81)\n10.100 (2.07)\n7.989 (0.85)\n8.61 (1.84)\n\n\n Median (IQR)\n9.000 (2.30)\n9.850 (2.85)\n8.000 (1.40)\n8.80 (1.75)\n\n\n P\n\nCIN P = .05\nDIN P = .08\n\n\n\nSepsis P = .01\nNo sepsis P = .00\n\n\nTTA\n\n\n\n Mean (SD)\n28.84 (14.91)\nNA\n37.78 (25.87)\nNA\n\n\n Median (IQR)\n20.00 (20.00)\nNA\n20.00 (40.00)\nNA\n\n\n P\n\nSepsis P = .48\n\n\nA\n\n\n\n\n\n\n Mean (SD)\n5.90 (4.30)\nNA\n5.22 (5.45)\nNA\n\n\n Median (IQR)\n4.00 (3.00)\nNA\n3.00 (5.50)\nNA\n\n\n P\n\nSepsis P = .0787\n\n\nG\n\n\n\n\n\n\n Mean (SD)\n4.00 (2.51)\nNA\n2.86 (3.18)\nNA\n\n\n Median (IQR)\n3.00 (4.00)\nNA\n1.00 (1.00)\nNA\n\n\n P\n\nSepsis P = .04\n\n\nIP\n\n\n\n\n\n\n Mean (SD)\n6.74 (5.36)\nNA\n6.78 (7.56)\nNA\n\n\n Median (IQR)\n5.00 (4.00)\nNA\n3.00 (8.50)\nNA\n\n\n P\n\nSepsis P = .2828\n\n\nDN\n\n\n\n\n\n\n Mean (SD)\n4.07 (3.04)\n4.37 (5.22)\nNA\nNA\n\n\n Median (IQR)\n3.00 (4.00)\n2.50 (3.75)\nNA\nNA\n\n\n P\n\nCIN P = .35\n\n\n\nOpen in a new tab\nAbbreviations: A, duration of antibiotics; CIN, chemotherapy-induced neutropenia; CRP, C-reactive protein; CSF, colony stimulating factors; CTN, chemotherapy to neutropenia in days; DIN, disease-induced neutropenia; DN, duration of neutropenia; G, duration of CSF; H, minimum hemoglobin; IP, inpatient stay; N, minimum neutrophil count; NA, not available; NTS, time from neutropenia to sepsis; P, minimum platelet count; SD, standard deviation; TTA, time to antibiotics from admission or from the onset of sepsis.The median neutrophil count in the group that had sepsis was 0.06, whereas it was 0.69 in the group that had no sepsis (P < .05; Fig 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "There was no difference in the CRP, median duration of antibiotic usage, CRP, GCSF usage, duration of neutropenia and hospital stay in the CINS group compared with the DINS group (Table 2; Fig 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Approval was obtained from the Lanka Hospitals medical and research committee.RESULTS\nA total of 169 neutropenic episodes were identified; 115 (68%) of such neutropenic episodes were related to chemotherapy, whereas 54 (32%) episodes were related to disease (Fig 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Fifteen percent of patients had only one episode of neutropenic sepsis during the study period, whereas 85% had more than one episode of neutropenic sepsis (Fig 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Acute leukemia/myelodysplastic syndrome, lymphoproliferative disorders, and plasma cell disorders accounted for 23%, 69%, and 8% of patients, respectively, in the group neutropenia related to chemotherapy (Fig 1C), whereas the majority of patients were male, 54% (Fig 1D).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The median age of patients who had CINS was 56 years, whereas that of those who had no sepsis was 53 years (P = .49; Fig 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The median time to neutropenia was 9 days for those in the sepsis group compared with 8 days in the group that had no sepsis (P = .64; Fig 2D).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel D",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Age and Time From CTN, NTS, CRP, N, P, H, TTA, A, G, IP, and DN in Chemotherapy-Induced and Disease-Induced neutropenia\n\n\n\nVariable\nChemotherapy-Induced Neutropenia\nDisease-Induced Neutropenia\n\n\nSepsis\nNo Sepsis\nSepsis\nNo Sepsis\n\n\n\n\nAge, years\n\n\n\n\n\n\n Mean (SD)\n50.40 (19.25)\n48.56 (19.83)\n64.33 (7.57)\n60.13 (7.84)\n\n\n Median (IQR)\n56.00 (36.00)\n53.00 (37.00)\n58.00 (15.00)\n58.00 (0.00)\n\n\n P\n\nCIN P = .49\nDIN P = .13\n\n\n\nSepsis P = .04\nNo sepsis P = .01\n\n\nCTN\n\n\n\n\n\n\n Mean (SD)\n9.34 (5.15)\n8.54 (3.73)\nNA\nNA\n\n\n Median (IQR)\n9.00 (5.00)\n8.00 (5.00)\nNA\nNA\n\n\n P\n\nCIN P = .64\nNA\nNA\n\n\nNTS\n\n\n\n\n\n Mean (SD)\n1.46 (1.120)\nNA\nNA\nNA\n\n\n Median (IQR)\n1.00 (0.00)\nNA\nNA\nNA\n\n\n P\n\nNA\nNA\nNA\nNA\n\n\nCRP\n\n\n\n\n\n\n Mean (SD)\n84.1 (98.5)\nNA\n80.0 (92.4)\nNA\n\n\n Median (IQR)\n47.6 (81.4)\nNA\n44.7 (133.1)\nNA\n\n\n P\n\nSepsis P = .83\n\n\nN\n\n\n\n Mean (SD)\n0.24 (0.32)\n0.62(0.29)\n0.45 (0.33)\n0.50 (0.36)\n\n\n Median (IQR)\n0.06 (0.46)\n0.69 (0.52)\n0.36 (0.66)\n0.50 (0.55)\n\n\n P\n\nCIN P = .000\nDIN P = .6176\n\n\n\nSepsis P = .018\nNo sepsis P = .02\n\n\nP\n\n\n\n Mean (SD)\n169.3 (134.9)\n186.6 (127.6)\n27.00 (26.66)\n48.0 (78.9)\n\n\n Median (IQR)\n139.0 (117.0)\n183.0 (132.0)\n16.00 (17.00)\n20.0 (24.0)\n\n\n P\n\nCIN P = .22\nDIN P = .47\n\n\n\nSepsis P = .00\nNo sepsis P = .00\n\n\nH\n\n\n\n Mean (SD)\n9.435 (1.81)\n10.100 (2.07)\n7.989 (0.85)\n8.61 (1.84)\n\n\n Median (IQR)\n9.000 (2.30)\n9.850 (2.85)\n8.000 (1.40)\n8.80 (1.75)\n\n\n P\n\nCIN P = .05\nDIN P = .08\n\n\n\nSepsis P = .01\nNo sepsis P = .00\n\n\nTTA\n\n\n\n Mean (SD)\n28.84 (14.91)\nNA\n37.78 (25.87)\nNA\n\n\n Median (IQR)\n20.00 (20.00)\nNA\n20.00 (40.00)\nNA\n\n\n P\n\nSepsis P = .48\n\n\nA\n\n\n\n\n\n\n Mean (SD)\n5.90 (4.30)\nNA\n5.22 (5.45)\nNA\n\n\n Median (IQR)\n4.00 (3.00)\nNA\n3.00 (5.50)\nNA\n\n\n P\n\nSepsis P = .0787\n\n\nG\n\n\n\n\n\n\n Mean (SD)\n4.00 (2.51)\nNA\n2.86 (3.18)\nNA\n\n\n Median (IQR)\n3.00 (4.00)\nNA\n1.00 (1.00)\nNA\n\n\n P\n\nSepsis P = .04\n\n\nIP\n\n\n\n\n\n\n Mean (SD)\n6.74 (5.36)\nNA\n6.78 (7.56)\nNA\n\n\n Median (IQR)\n5.00 (4.00)\nNA\n3.00 (8.50)\nNA\n\n\n P\n\nSepsis P = .2828\n\n\nDN\n\n\n\n\n\n\n Mean (SD)\n4.07 (3.04)\n4.37 (5.22)\nNA\nNA\n\n\n Median (IQR)\n3.00 (4.00)\n2.50 (3.75)\nNA\nNA\n\n\n P\n\nCIN P = .35\n\n\n\nOpen in a new tab\nAbbreviations: A, duration of antibiotics; CIN, chemotherapy-induced neutropenia; CRP, C-reactive protein; CSF, colony stimulating factors; CTN, chemotherapy to neutropenia in days; DIN, disease-induced neutropenia; DN, duration of neutropenia; G, duration of CSF; H, minimum hemoglobin; IP, inpatient stay; N, minimum neutrophil count; NA, not available; NTS, time from neutropenia to sepsis; P, minimum platelet count; SD, standard deviation; TTA, time to antibiotics from admission or from the onset of sepsis.The median neutrophil count in the group that had sepsis was 0.06, whereas it was 0.69 in the group that had no sepsis (P < .05; Fig 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "There was no difference in the CRP, median duration of antibiotic usage, CRP, GCSF usage, duration of neutropenia and hospital stay in the CINS group compared with the DINS group (Table 2; Fig 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Approval was obtained from the Lanka Hospitals medical and research committee.RESULTS\nA total of 169 neutropenic episodes were identified; 115 (68%) of such neutropenic episodes were related to chemotherapy, whereas 54 (32%) episodes were related to disease (Fig 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Fifteen percent of patients had only one episode of neutropenic sepsis during the study period, whereas 85% had more than one episode of neutropenic sepsis (Fig 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Acute leukemia/myelodysplastic syndrome, lymphoproliferative disorders, and plasma cell disorders accounted for 23%, 69%, and 8% of patients, respectively, in the group neutropenia related to chemotherapy (Fig 1C), whereas the majority of patients were male, 54% (Fig 1D).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The median age of patients who had CINS was 56 years, whereas that of those who had no sepsis was 53 years (P = .49; Fig 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The median time to neutropenia was 9 days for those in the sepsis group compared with 8 days in the group that had no sepsis (P = .64; Fig 2D).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel D",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Age and Time From CTN, NTS, CRP, N, P, H, TTA, A, G, IP, and DN in Chemotherapy-Induced and Disease-Induced neutropenia\n\n\n\nVariable\nChemotherapy-Induced Neutropenia\nDisease-Induced Neutropenia\n\n\nSepsis\nNo Sepsis\nSepsis\nNo Sepsis\n\n\n\n\nAge, years\n\n\n\n\n\n\n Mean (SD)\n50.40 (19.25)\n48.56 (19.83)\n64.33 (7.57)\n60.13 (7.84)\n\n\n Median (IQR)\n56.00 (36.00)\n53.00 (37.00)\n58.00 (15.00)\n58.00 (0.00)\n\n\n P\n\nCIN P = .49\nDIN P = .13\n\n\n\nSepsis P = .04\nNo sepsis P = .01\n\n\nCTN\n\n\n\n\n\n\n Mean (SD)\n9.34 (5.15)\n8.54 (3.73)\nNA\nNA\n\n\n Median (IQR)\n9.00 (5.00)\n8.00 (5.00)\nNA\nNA\n\n\n P\n\nCIN P = .64\nNA\nNA\n\n\nNTS\n\n\n\n\n\n Mean (SD)\n1.46 (1.120)\nNA\nNA\nNA\n\n\n Median (IQR)\n1.00 (0.00)\nNA\nNA\nNA\n\n\n P\n\nNA\nNA\nNA\nNA\n\n\nCRP\n\n\n\n\n\n\n Mean (SD)\n84.1 (98.5)\nNA\n80.0 (92.4)\nNA\n\n\n Median (IQR)\n47.6 (81.4)\nNA\n44.7 (133.1)\nNA\n\n\n P\n\nSepsis P = .83\n\n\nN\n\n\n\n Mean (SD)\n0.24 (0.32)\n0.62(0.29)\n0.45 (0.33)\n0.50 (0.36)\n\n\n Median (IQR)\n0.06 (0.46)\n0.69 (0.52)\n0.36 (0.66)\n0.50 (0.55)\n\n\n P\n\nCIN P = .000\nDIN P = .6176\n\n\n\nSepsis P = .018\nNo sepsis P = .02\n\n\nP\n\n\n\n Mean (SD)\n169.3 (134.9)\n186.6 (127.6)\n27.00 (26.66)\n48.0 (78.9)\n\n\n Median (IQR)\n139.0 (117.0)\n183.0 (132.0)\n16.00 (17.00)\n20.0 (24.0)\n\n\n P\n\nCIN P = .22\nDIN P = .47\n\n\n\nSepsis P = .00\nNo sepsis P = .00\n\n\nH\n\n\n\n Mean (SD)\n9.435 (1.81)\n10.100 (2.07)\n7.989 (0.85)\n8.61 (1.84)\n\n\n Median (IQR)\n9.000 (2.30)\n9.850 (2.85)\n8.000 (1.40)\n8.80 (1.75)\n\n\n P\n\nCIN P = .05\nDIN P = .08\n\n\n\nSepsis P = .01\nNo sepsis P = .00\n\n\nTTA\n\n\n\n Mean (SD)\n28.84 (14.91)\nNA\n37.78 (25.87)\nNA\n\n\n Median (IQR)\n20.00 (20.00)\nNA\n20.00 (40.00)\nNA\n\n\n P\n\nSepsis P = .48\n\n\nA\n\n\n\n\n\n\n Mean (SD)\n5.90 (4.30)\nNA\n5.22 (5.45)\nNA\n\n\n Median (IQR)\n4.00 (3.00)\nNA\n3.00 (5.50)\nNA\n\n\n P\n\nSepsis P = .0787\n\n\nG\n\n\n\n\n\n\n Mean (SD)\n4.00 (2.51)\nNA\n2.86 (3.18)\nNA\n\n\n Median (IQR)\n3.00 (4.00)\nNA\n1.00 (1.00)\nNA\n\n\n P\n\nSepsis P = .04\n\n\nIP\n\n\n\n\n\n\n Mean (SD)\n6.74 (5.36)\nNA\n6.78 (7.56)\nNA\n\n\n Median (IQR)\n5.00 (4.00)\nNA\n3.00 (8.50)\nNA\n\n\n P\n\nSepsis P = .2828\n\n\nDN\n\n\n\n\n\n\n Mean (SD)\n4.07 (3.04)\n4.37 (5.22)\nNA\nNA\n\n\n Median (IQR)\n3.00 (4.00)\n2.50 (3.75)\nNA\nNA\n\n\n P\n\nCIN P = .35\n\n\n\nOpen in a new tab\nAbbreviations: A, duration of antibiotics; CIN, chemotherapy-induced neutropenia; CRP, C-reactive protein; CSF, colony stimulating factors; CTN, chemotherapy to neutropenia in days; DIN, disease-induced neutropenia; DN, duration of neutropenia; G, duration of CSF; H, minimum hemoglobin; IP, inpatient stay; N, minimum neutrophil count; NA, not available; NTS, time from neutropenia to sepsis; P, minimum platelet count; SD, standard deviation; TTA, time to antibiotics from admission or from the onset of sepsis.The median neutrophil count in the group that had sepsis was 0.06, whereas it was 0.69 in the group that had no sepsis (P < .05; Fig 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "There was no difference in the CRP, median duration of antibiotic usage, CRP, GCSF usage, duration of neutropenia and hospital stay in the CINS group compared with the DINS group (Table 2; Fig 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Approval was obtained from the Lanka Hospitals medical and research committee.RESULTS\nA total of 169 neutropenic episodes were identified; 115 (68%) of such neutropenic episodes were related to chemotherapy, whereas 54 (32%) episodes were related to disease (Fig 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Fifteen percent of patients had only one episode of neutropenic sepsis during the study period, whereas 85% had more than one episode of neutropenic sepsis (Fig 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Acute leukemia/myelodysplastic syndrome, lymphoproliferative disorders, and plasma cell disorders accounted for 23%, 69%, and 8% of patients, respectively, in the group neutropenia related to chemotherapy (Fig 1C), whereas the majority of patients were male, 54% (Fig 1D).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The median age of patients who had CINS was 56 years, whereas that of those who had no sepsis was 53 years (P = .49; Fig 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The median time to neutropenia was 9 days for those in the sepsis group compared with 8 days in the group that had no sepsis (P = .64; Fig 2D).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel D",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Age and Time From CTN, NTS, CRP, N, P, H, TTA, A, G, IP, and DN in Chemotherapy-Induced and Disease-Induced neutropenia\n\n\n\nVariable\nChemotherapy-Induced Neutropenia\nDisease-Induced Neutropenia\n\n\nSepsis\nNo Sepsis\nSepsis\nNo Sepsis\n\n\n\n\nAge, years\n\n\n\n\n\n\n Mean (SD)\n50.40 (19.25)\n48.56 (19.83)\n64.33 (7.57)\n60.13 (7.84)\n\n\n Median (IQR)\n56.00 (36.00)\n53.00 (37.00)\n58.00 (15.00)\n58.00 (0.00)\n\n\n P\n\nCIN P = .49\nDIN P = .13\n\n\n\nSepsis P = .04\nNo sepsis P = .01\n\n\nCTN\n\n\n\n\n\n\n Mean (SD)\n9.34 (5.15)\n8.54 (3.73)\nNA\nNA\n\n\n Median (IQR)\n9.00 (5.00)\n8.00 (5.00)\nNA\nNA\n\n\n P\n\nCIN P = .64\nNA\nNA\n\n\nNTS\n\n\n\n\n\n Mean (SD)\n1.46 (1.120)\nNA\nNA\nNA\n\n\n Median (IQR)\n1.00 (0.00)\nNA\nNA\nNA\n\n\n P\n\nNA\nNA\nNA\nNA\n\n\nCRP\n\n\n\n\n\n\n Mean (SD)\n84.1 (98.5)\nNA\n80.0 (92.4)\nNA\n\n\n Median (IQR)\n47.6 (81.4)\nNA\n44.7 (133.1)\nNA\n\n\n P\n\nSepsis P = .83\n\n\nN\n\n\n\n Mean (SD)\n0.24 (0.32)\n0.62(0.29)\n0.45 (0.33)\n0.50 (0.36)\n\n\n Median (IQR)\n0.06 (0.46)\n0.69 (0.52)\n0.36 (0.66)\n0.50 (0.55)\n\n\n P\n\nCIN P = .000\nDIN P = .6176\n\n\n\nSepsis P = .018\nNo sepsis P = .02\n\n\nP\n\n\n\n Mean (SD)\n169.3 (134.9)\n186.6 (127.6)\n27.00 (26.66)\n48.0 (78.9)\n\n\n Median (IQR)\n139.0 (117.0)\n183.0 (132.0)\n16.00 (17.00)\n20.0 (24.0)\n\n\n P\n\nCIN P = .22\nDIN P = .47\n\n\n\nSepsis P = .00\nNo sepsis P = .00\n\n\nH\n\n\n\n Mean (SD)\n9.435 (1.81)\n10.100 (2.07)\n7.989 (0.85)\n8.61 (1.84)\n\n\n Median (IQR)\n9.000 (2.30)\n9.850 (2.85)\n8.000 (1.40)\n8.80 (1.75)\n\n\n P\n\nCIN P = .05\nDIN P = .08\n\n\n\nSepsis P = .01\nNo sepsis P = .00\n\n\nTTA\n\n\n\n Mean (SD)\n28.84 (14.91)\nNA\n37.78 (25.87)\nNA\n\n\n Median (IQR)\n20.00 (20.00)\nNA\n20.00 (40.00)\nNA\n\n\n P\n\nSepsis P = .48\n\n\nA\n\n\n\n\n\n\n Mean (SD)\n5.90 (4.30)\nNA\n5.22 (5.45)\nNA\n\n\n Median (IQR)\n4.00 (3.00)\nNA\n3.00 (5.50)\nNA\n\n\n P\n\nSepsis P = .0787\n\n\nG\n\n\n\n\n\n\n Mean (SD)\n4.00 (2.51)\nNA\n2.86 (3.18)\nNA\n\n\n Median (IQR)\n3.00 (4.00)\nNA\n1.00 (1.00)\nNA\n\n\n P\n\nSepsis P = .04\n\n\nIP\n\n\n\n\n\n\n Mean (SD)\n6.74 (5.36)\nNA\n6.78 (7.56)\nNA\n\n\n Median (IQR)\n5.00 (4.00)\nNA\n3.00 (8.50)\nNA\n\n\n P\n\nSepsis P = .2828\n\n\nDN\n\n\n\n\n\n\n Mean (SD)\n4.07 (3.04)\n4.37 (5.22)\nNA\nNA\n\n\n Median (IQR)\n3.00 (4.00)\n2.50 (3.75)\nNA\nNA\n\n\n P\n\nCIN P = .35\n\n\n\nOpen in a new tab\nAbbreviations: A, duration of antibiotics; CIN, chemotherapy-induced neutropenia; CRP, C-reactive protein; CSF, colony stimulating factors; CTN, chemotherapy to neutropenia in days; DIN, disease-induced neutropenia; DN, duration of neutropenia; G, duration of CSF; H, minimum hemoglobin; IP, inpatient stay; N, minimum neutrophil count; NA, not available; NTS, time from neutropenia to sepsis; P, minimum platelet count; SD, standard deviation; TTA, time to antibiotics from admission or from the onset of sepsis.The median neutrophil count in the group that had sepsis was 0.06, whereas it was 0.69 in the group that had no sepsis (P < .05; Fig 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "There was no difference in the CRP, median duration of antibiotic usage, CRP, GCSF usage, duration of neutropenia and hospital stay in the CINS group compared with the DINS group (Table 2; Fig 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Approval was obtained from the Lanka Hospitals medical and research committee.RESULTS\nA total of 169 neutropenic episodes were identified; 115 (68%) of such neutropenic episodes were related to chemotherapy, whereas 54 (32%) episodes were related to disease (Fig 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Fifteen percent of patients had only one episode of neutropenic sepsis during the study period, whereas 85% had more than one episode of neutropenic sepsis (Fig 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Acute leukemia/myelodysplastic syndrome, lymphoproliferative disorders, and plasma cell disorders accounted for 23%, 69%, and 8% of patients, respectively, in the group neutropenia related to chemotherapy (Fig 1C), whereas the majority of patients were male, 54% (Fig 1D).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The median age of patients who had CINS was 56 years, whereas that of those who had no sepsis was 53 years (P = .49; Fig 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The median time to neutropenia was 9 days for those in the sepsis group compared with 8 days in the group that had no sepsis (P = .64; Fig 2D).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel D",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Age and Time From CTN, NTS, CRP, N, P, H, TTA, A, G, IP, and DN in Chemotherapy-Induced and Disease-Induced neutropenia\n\n\n\nVariable\nChemotherapy-Induced Neutropenia\nDisease-Induced Neutropenia\n\n\nSepsis\nNo Sepsis\nSepsis\nNo Sepsis\n\n\n\n\nAge, years\n\n\n\n\n\n\n Mean (SD)\n50.40 (19.25)\n48.56 (19.83)\n64.33 (7.57)\n60.13 (7.84)\n\n\n Median (IQR)\n56.00 (36.00)\n53.00 (37.00)\n58.00 (15.00)\n58.00 (0.00)\n\n\n P\n\nCIN P = .49\nDIN P = .13\n\n\n\nSepsis P = .04\nNo sepsis P = .01\n\n\nCTN\n\n\n\n\n\n\n Mean (SD)\n9.34 (5.15)\n8.54 (3.73)\nNA\nNA\n\n\n Median (IQR)\n9.00 (5.00)\n8.00 (5.00)\nNA\nNA\n\n\n P\n\nCIN P = .64\nNA\nNA\n\n\nNTS\n\n\n\n\n\n Mean (SD)\n1.46 (1.120)\nNA\nNA\nNA\n\n\n Median (IQR)\n1.00 (0.00)\nNA\nNA\nNA\n\n\n P\n\nNA\nNA\nNA\nNA\n\n\nCRP\n\n\n\n\n\n\n Mean (SD)\n84.1 (98.5)\nNA\n80.0 (92.4)\nNA\n\n\n Median (IQR)\n47.6 (81.4)\nNA\n44.7 (133.1)\nNA\n\n\n P\n\nSepsis P = .83\n\n\nN\n\n\n\n Mean (SD)\n0.24 (0.32)\n0.62(0.29)\n0.45 (0.33)\n0.50 (0.36)\n\n\n Median (IQR)\n0.06 (0.46)\n0.69 (0.52)\n0.36 (0.66)\n0.50 (0.55)\n\n\n P\n\nCIN P = .000\nDIN P = .6176\n\n\n\nSepsis P = .018\nNo sepsis P = .02\n\n\nP\n\n\n\n Mean (SD)\n169.3 (134.9)\n186.6 (127.6)\n27.00 (26.66)\n48.0 (78.9)\n\n\n Median (IQR)\n139.0 (117.0)\n183.0 (132.0)\n16.00 (17.00)\n20.0 (24.0)\n\n\n P\n\nCIN P = .22\nDIN P = .47\n\n\n\nSepsis P = .00\nNo sepsis P = .00\n\n\nH\n\n\n\n Mean (SD)\n9.435 (1.81)\n10.100 (2.07)\n7.989 (0.85)\n8.61 (1.84)\n\n\n Median (IQR)\n9.000 (2.30)\n9.850 (2.85)\n8.000 (1.40)\n8.80 (1.75)\n\n\n P\n\nCIN P = .05\nDIN P = .08\n\n\n\nSepsis P = .01\nNo sepsis P = .00\n\n\nTTA\n\n\n\n Mean (SD)\n28.84 (14.91)\nNA\n37.78 (25.87)\nNA\n\n\n Median (IQR)\n20.00 (20.00)\nNA\n20.00 (40.00)\nNA\n\n\n P\n\nSepsis P = .48\n\n\nA\n\n\n\n\n\n\n Mean (SD)\n5.90 (4.30)\nNA\n5.22 (5.45)\nNA\n\n\n Median (IQR)\n4.00 (3.00)\nNA\n3.00 (5.50)\nNA\n\n\n P\n\nSepsis P = .0787\n\n\nG\n\n\n\n\n\n\n Mean (SD)\n4.00 (2.51)\nNA\n2.86 (3.18)\nNA\n\n\n Median (IQR)\n3.00 (4.00)\nNA\n1.00 (1.00)\nNA\n\n\n P\n\nSepsis P = .04\n\n\nIP\n\n\n\n\n\n\n Mean (SD)\n6.74 (5.36)\nNA\n6.78 (7.56)\nNA\n\n\n Median (IQR)\n5.00 (4.00)\nNA\n3.00 (8.50)\nNA\n\n\n P\n\nSepsis P = .2828\n\n\nDN\n\n\n\n\n\n\n Mean (SD)\n4.07 (3.04)\n4.37 (5.22)\nNA\nNA\n\n\n Median (IQR)\n3.00 (4.00)\n2.50 (3.75)\nNA\nNA\n\n\n P\n\nCIN P = .35\n\n\n\nOpen in a new tab\nAbbreviations: A, duration of antibiotics; CIN, chemotherapy-induced neutropenia; CRP, C-reactive protein; CSF, colony stimulating factors; CTN, chemotherapy to neutropenia in days; DIN, disease-induced neutropenia; DN, duration of neutropenia; G, duration of CSF; H, minimum hemoglobin; IP, inpatient stay; N, minimum neutrophil count; NA, not available; NTS, time from neutropenia to sepsis; P, minimum platelet count; SD, standard deviation; TTA, time to antibiotics from admission or from the onset of sepsis.The median neutrophil count in the group that had sepsis was 0.06, whereas it was 0.69 in the group that had no sepsis (P < .05; Fig 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "There was no difference in the CRP, median duration of antibiotic usage, CRP, GCSF usage, duration of neutropenia and hospital stay in the CINS group compared with the DINS group (Table 2; Fig 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Approval was obtained from the Lanka Hospitals medical and research committee.RESULTS\nA total of 169 neutropenic episodes were identified; 115 (68%) of such neutropenic episodes were related to chemotherapy, whereas 54 (32%) episodes were related to disease (Fig 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Fifteen percent of patients had only one episode of neutropenic sepsis during the study period, whereas 85% had more than one episode of neutropenic sepsis (Fig 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Acute leukemia/myelodysplastic syndrome, lymphoproliferative disorders, and plasma cell disorders accounted for 23%, 69%, and 8% of patients, respectively, in the group neutropenia related to chemotherapy (Fig 1C), whereas the majority of patients were male, 54% (Fig 1D).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The median age of patients who had CINS was 56 years, whereas that of those who had no sepsis was 53 years (P = .49; Fig 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The median time to neutropenia was 9 days for those in the sepsis group compared with 8 days in the group that had no sepsis (P = .64; Fig 2D).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel D",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Age and Time From CTN, NTS, CRP, N, P, H, TTA, A, G, IP, and DN in Chemotherapy-Induced and Disease-Induced neutropenia\n\n\n\nVariable\nChemotherapy-Induced Neutropenia\nDisease-Induced Neutropenia\n\n\nSepsis\nNo Sepsis\nSepsis\nNo Sepsis\n\n\n\n\nAge, years\n\n\n\n\n\n\n Mean (SD)\n50.40 (19.25)\n48.56 (19.83)\n64.33 (7.57)\n60.13 (7.84)\n\n\n Median (IQR)\n56.00 (36.00)\n53.00 (37.00)\n58.00 (15.00)\n58.00 (0.00)\n\n\n P\n\nCIN P = .49\nDIN P = .13\n\n\n\nSepsis P = .04\nNo sepsis P = .01\n\n\nCTN\n\n\n\n\n\n\n Mean (SD)\n9.34 (5.15)\n8.54 (3.73)\nNA\nNA\n\n\n Median (IQR)\n9.00 (5.00)\n8.00 (5.00)\nNA\nNA\n\n\n P\n\nCIN P = .64\nNA\nNA\n\n\nNTS\n\n\n\n\n\n Mean (SD)\n1.46 (1.120)\nNA\nNA\nNA\n\n\n Median (IQR)\n1.00 (0.00)\nNA\nNA\nNA\n\n\n P\n\nNA\nNA\nNA\nNA\n\n\nCRP\n\n\n\n\n\n\n Mean (SD)\n84.1 (98.5)\nNA\n80.0 (92.4)\nNA\n\n\n Median (IQR)\n47.6 (81.4)\nNA\n44.7 (133.1)\nNA\n\n\n P\n\nSepsis P = .83\n\n\nN\n\n\n\n Mean (SD)\n0.24 (0.32)\n0.62(0.29)\n0.45 (0.33)\n0.50 (0.36)\n\n\n Median (IQR)\n0.06 (0.46)\n0.69 (0.52)\n0.36 (0.66)\n0.50 (0.55)\n\n\n P\n\nCIN P = .000\nDIN P = .6176\n\n\n\nSepsis P = .018\nNo sepsis P = .02\n\n\nP\n\n\n\n Mean (SD)\n169.3 (134.9)\n186.6 (127.6)\n27.00 (26.66)\n48.0 (78.9)\n\n\n Median (IQR)\n139.0 (117.0)\n183.0 (132.0)\n16.00 (17.00)\n20.0 (24.0)\n\n\n P\n\nCIN P = .22\nDIN P = .47\n\n\n\nSepsis P = .00\nNo sepsis P = .00\n\n\nH\n\n\n\n Mean (SD)\n9.435 (1.81)\n10.100 (2.07)\n7.989 (0.85)\n8.61 (1.84)\n\n\n Median (IQR)\n9.000 (2.30)\n9.850 (2.85)\n8.000 (1.40)\n8.80 (1.75)\n\n\n P\n\nCIN P = .05\nDIN P = .08\n\n\n\nSepsis P = .01\nNo sepsis P = .00\n\n\nTTA\n\n\n\n Mean (SD)\n28.84 (14.91)\nNA\n37.78 (25.87)\nNA\n\n\n Median (IQR)\n20.00 (20.00)\nNA\n20.00 (40.00)\nNA\n\n\n P\n\nSepsis P = .48\n\n\nA\n\n\n\n\n\n\n Mean (SD)\n5.90 (4.30)\nNA\n5.22 (5.45)\nNA\n\n\n Median (IQR)\n4.00 (3.00)\nNA\n3.00 (5.50)\nNA\n\n\n P\n\nSepsis P = .0787\n\n\nG\n\n\n\n\n\n\n Mean (SD)\n4.00 (2.51)\nNA\n2.86 (3.18)\nNA\n\n\n Median (IQR)\n3.00 (4.00)\nNA\n1.00 (1.00)\nNA\n\n\n P\n\nSepsis P = .04\n\n\nIP\n\n\n\n\n\n\n Mean (SD)\n6.74 (5.36)\nNA\n6.78 (7.56)\nNA\n\n\n Median (IQR)\n5.00 (4.00)\nNA\n3.00 (8.50)\nNA\n\n\n P\n\nSepsis P = .2828\n\n\nDN\n\n\n\n\n\n\n Mean (SD)\n4.07 (3.04)\n4.37 (5.22)\nNA\nNA\n\n\n Median (IQR)\n3.00 (4.00)\n2.50 (3.75)\nNA\nNA\n\n\n P\n\nCIN P = .35\n\n\n\nOpen in a new tab\nAbbreviations: A, duration of antibiotics; CIN, chemotherapy-induced neutropenia; CRP, C-reactive protein; CSF, colony stimulating factors; CTN, chemotherapy to neutropenia in days; DIN, disease-induced neutropenia; DN, duration of neutropenia; G, duration of CSF; H, minimum hemoglobin; IP, inpatient stay; N, minimum neutrophil count; NA, not available; NTS, time from neutropenia to sepsis; P, minimum platelet count; SD, standard deviation; TTA, time to antibiotics from admission or from the onset of sepsis.The median neutrophil count in the group that had sepsis was 0.06, whereas it was 0.69 in the group that had no sepsis (P < .05; Fig 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "There was no difference in the CRP, median duration of antibiotic usage, CRP, GCSF usage, duration of neutropenia and hospital stay in the CINS group compared with the DINS group (Table 2; Fig 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "RESULTS\nA total of 169 neutropenic episodes were identified; 115 (68%) of such neutropenic episodes were related to chemotherapy, whereas 54 (32%) episodes were related to disease (Fig 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Fifteen percent of patients had only one episode of neutropenic sepsis during the study period, whereas 85% had more than one episode of neutropenic sepsis (Fig 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Acute leukemia/myelodysplastic syndrome, lymphoproliferative disorders, and plasma cell disorders accounted for 23%, 69%, and 8% of patients, respectively, in the group neutropenia related to chemotherapy (Fig 1C), whereas the majority of patients were male, 54% (Fig 1D).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The median age of patients who had CINS was 56 years, whereas that of those who had no sepsis was 53 years (P = .49; Fig 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The median time to neutropenia was 9 days for those in the sepsis group compared with 8 days in the group that had no sepsis (P = .64; Fig 2D).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel D",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Age and Time From CTN, NTS, CRP, N, P, H, TTA, A, G, IP, and DN in Chemotherapy-Induced and Disease-Induced neutropenia\n\n\n\nVariable\nChemotherapy-Induced Neutropenia\nDisease-Induced Neutropenia\n\n\nSepsis\nNo Sepsis\nSepsis\nNo Sepsis\n\n\n\n\nAge, years\n\n\n\n\n\n\n Mean (SD)\n50.40 (19.25)\n48.56 (19.83)\n64.33 (7.57)\n60.13 (7.84)\n\n\n Median (IQR)\n56.00 (36.00)\n53.00 (37.00)\n58.00 (15.00)\n58.00 (0.00)\n\n\n P\n\nCIN P = .49\nDIN P = .13\n\n\n\nSepsis P = .04\nNo sepsis P = .01\n\n\nCTN\n\n\n\n\n\n\n Mean (SD)\n9.34 (5.15)\n8.54 (3.73)\nNA\nNA\n\n\n Median (IQR)\n9.00 (5.00)\n8.00 (5.00)\nNA\nNA\n\n\n P\n\nCIN P = .64\nNA\nNA\n\n\nNTS\n\n\n\n\n\n Mean (SD)\n1.46 (1.120)\nNA\nNA\nNA\n\n\n Median (IQR)\n1.00 (0.00)\nNA\nNA\nNA\n\n\n P\n\nNA\nNA\nNA\nNA\n\n\nCRP\n\n\n\n\n\n\n Mean (SD)\n84.1 (98.5)\nNA\n80.0 (92.4)\nNA\n\n\n Median (IQR)\n47.6 (81.4)\nNA\n44.7 (133.1)\nNA\n\n\n P\n\nSepsis P = .83\n\n\nN\n\n\n\n Mean (SD)\n0.24 (0.32)\n0.62(0.29)\n0.45 (0.33)\n0.50 (0.36)\n\n\n Median (IQR)\n0.06 (0.46)\n0.69 (0.52)\n0.36 (0.66)\n0.50 (0.55)\n\n\n P\n\nCIN P = .000\nDIN P = .6176\n\n\n\nSepsis P = .018\nNo sepsis P = .02\n\n\nP\n\n\n\n Mean (SD)\n169.3 (134.9)\n186.6 (127.6)\n27.00 (26.66)\n48.0 (78.9)\n\n\n Median (IQR)\n139.0 (117.0)\n183.0 (132.0)\n16.00 (17.00)\n20.0 (24.0)\n\n\n P\n\nCIN P = .22\nDIN P = .47\n\n\n\nSepsis P = .00\nNo sepsis P = .00\n\n\nH\n\n\n\n Mean (SD)\n9.435 (1.81)\n10.100 (2.07)\n7.989 (0.85)\n8.61 (1.84)\n\n\n Median (IQR)\n9.000 (2.30)\n9.850 (2.85)\n8.000 (1.40)\n8.80 (1.75)\n\n\n P\n\nCIN P = .05\nDIN P = .08\n\n\n\nSepsis P = .01\nNo sepsis P = .00\n\n\nTTA\n\n\n\n Mean (SD)\n28.84 (14.91)\nNA\n37.78 (25.87)\nNA\n\n\n Median (IQR)\n20.00 (20.00)\nNA\n20.00 (40.00)\nNA\n\n\n P\n\nSepsis P = .48\n\n\nA\n\n\n\n\n\n\n Mean (SD)\n5.90 (4.30)\nNA\n5.22 (5.45)\nNA\n\n\n Median (IQR)\n4.00 (3.00)\nNA\n3.00 (5.50)\nNA\n\n\n P\n\nSepsis P = .0787\n\n\nG\n\n\n\n\n\n\n Mean (SD)\n4.00 (2.51)\nNA\n2.86 (3.18)\nNA\n\n\n Median (IQR)\n3.00 (4.00)\nNA\n1.00 (1.00)\nNA\n\n\n P\n\nSepsis P = .04\n\n\nIP\n\n\n\n\n\n\n Mean (SD)\n6.74 (5.36)\nNA\n6.78 (7.56)\nNA\n\n\n Median (IQR)\n5.00 (4.00)\nNA\n3.00 (8.50)\nNA\n\n\n P\n\nSepsis P = .2828\n\n\nDN\n\n\n\n\n\n\n Mean (SD)\n4.07 (3.04)\n4.37 (5.22)\nNA\nNA\n\n\n Median (IQR)\n3.00 (4.00)\n2.50 (3.75)\nNA\nNA\n\n\n P\n\nCIN P = .35\n\n\n\nOpen in a new tab\nAbbreviations: A, duration of antibiotics; CIN, chemotherapy-induced neutropenia; CRP, C-reactive protein; CSF, colony stimulating factors; CTN, chemotherapy to neutropenia in days; DIN, disease-induced neutropenia; DN, duration of neutropenia; G, duration of CSF; H, minimum hemoglobin; IP, inpatient stay; N, minimum neutrophil count; NA, not available; NTS, time from neutropenia to sepsis; P, minimum platelet count; SD, standard deviation; TTA, time to antibiotics from admission or from the onset of sepsis.The median neutrophil count in the group that had sepsis was 0.06, whereas it was 0.69 in the group that had no sepsis (P < .05; Fig 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "There was no difference in the CRP, median duration of antibiotic usage, CRP, GCSF usage, duration of neutropenia and hospital stay in the CINS group compared with the DINS group (Table 2; Fig 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "A total of 169 neutropenic episodes were identified; 115 (68%) of such neutropenic episodes were related to chemotherapy, whereas 54 (32%) episodes were related to disease (Fig 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Fifteen percent of patients had only one episode of neutropenic sepsis during the study period, whereas 85% had more than one episode of neutropenic sepsis (Fig 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Acute leukemia/myelodysplastic syndrome, lymphoproliferative disorders, and plasma cell disorders accounted for 23%, 69%, and 8% of patients, respectively, in the group neutropenia related to chemotherapy (Fig 1C), whereas the majority of patients were male, 54% (Fig 1D).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The median age of patients who had CINS was 56 years, whereas that of those who had no sepsis was 53 years (P = .49; Fig 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The median time to neutropenia was 9 days for those in the sepsis group compared with 8 days in the group that had no sepsis (P = .64; Fig 2D).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel D",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The median neutrophil count in the group that had sepsis was 0.06, whereas it was 0.69 in the group that had no sepsis (P < .05; Fig 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "There was no difference in the CRP, median duration of antibiotic usage, CRP, GCSF usage, duration of neutropenia and hospital stay in the CINS group compared with the DINS group (Table 2; Fig 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  }
]